Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Urologix has entered into a co-development agreement with ProUroCare Medical, and Rensselaer Polytechnic Institute, to develop a real-time temperature imaging system. The system, to be called ProUroVision, will be combined with Urologix' Cooled ThermoTherapy treatment of benign prostatic hyperplasia.
Subscribe to our email newsletter
Cooled ThermoTherapy uses targeted microwave energy combined with a unique cooling mechanism to provide safe, effective and lasting relief from benign prostatic hyperplasia (BPH) symptoms. BPH, also known as enlarged prostate disease, is a non-cancerous condition that can make urination difficult or painful and is common in men over the age of 50.
“We look forward to working with the researchers at Rensselaer Polytechnic Institute and the scientific and engineering team at ProUroCare,” said David Montecalvo, Urologix vice president of product development and operations.
“If successful, we will be able to provide accurate discrete temperature measurements at multiple points in the prostate. This information will allow our treating physicians to view an image of the patients’ prostate during the procedure, showing the heating effect and associated tissue necrosis resulting from our Cooled ThermoTherapy treatment in real-time.”